Ying Lu
department
Blood Transfusion
Introduction

Ying Lu, MD,PhD

 

Title

Associate Chief  Doctor,  Department of Blood Transfusion

 

Research Interests

  • Clinical blood transfusion

  • Hemapheresis  in hematology disease and immune disease

  • Autophagy in leukemia

 

Education and experiences

Education

  • Sun Yat-Sen University, Guangzhou, China, Ph. D in Hematology                       Jun. 2015

  • Sun Yat-Sen University, Guangzhou China, Postgraduate in Hematology          Jun. 2005

  • Jiangxi Medical College, Jiangxi, China, MD in Clinical Medicine                         Jun. 2002


Experience

  • Associate Chief  Doctor  (2017-present) 

    Department of Blood Transfusion, The Third Affiliated Hospital, Sun Yat-Sen University

  • Attending Physician  (2015-2016)

    Department of Blood Transfusion, The Third Affiliated Hospital, Sun Yat-Sen University

  • Attending Physician (2009-2015)

    Department of Hematology, The Third Affiliated Hospital, Sun Yat-Sen University

  • Resident (2005-2008)

    The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China



SELECTED PUBLICATIONS

1 Fan RF, Lu Y, Fang ZG, Guo XY, Chen YX, Xu YC, Lei YM, Liu KF, Lin DJ, Liu LL, Liu XF. PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β. Mol Med Rep. 2017, 16: 4603-4612. (Co-first author)

2 Liu X, Fan R, Lu Y, Kuang L, Yuan Q, Chen Y, Lin Z, Lin D.Influence of autologous blood transfusion in liver transplantation in patients with hepatitis B on the function and hemorheology of red blood cells. Exp Ther Med. 2017, 14(2):1205-1211. (Co-first author)

3 Qu C, Lu Y, Liu W. Severe bone marrow suppression accompanying pulmonary infection and hemorrhage of the digestive tract associated with leflunomide and low-dose methotrexate combination therapy. J Pharmacol Pharmacother. 2017, 8(1): 35-37.

4 Lu Y, Liu LL, Liu SS, Fang ZG, Zou Y, Deng XB, Long ZJ, Liu Q, Lin DJ. Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib- resistant chronic myeloid leukemia cells. J Transl Med.2016, 14: 270

5 Lu Y, Liu XF, Liu TR, Fan RF, Xu YC, Zhang XZ, Liu LL. Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function. Biomed Pharmacother. 2016; 84:1551-1557

6 Pan GZ, Zhai FX, Lu Y, Fang ZG, Fan RF, Liu XF, Lin DJ. RUNX3 plays an important role in As2O3‑induced apoptosis and allows cells to overcome MSC- mediated drug resistance. Oncol Rep. 2016, 36(4):1927-1938. 

7 Zou Y, Song ZX, Liang XL, Yuan Q, Liao SH, Bao JJ. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immune depression in patients with β- thalassemia major. J Huazhong Univ Sci Technolog Med Sci. 2016, 36(4):509-513.

8 Fan RF, Chen XY, Fang ZG, Guo XY, Lu Y, Liu LL. Zoledronic acid overcomes adriamycin resis-

tance in acute myeloid leukemia cells by promoting apoptosis. Mol Med Rep. 2016, 14(6): 5660-5666.

9 Liu S, Wang X, Lu Y, Xiao J, Liang J, Zhong X, Chen Y. The combined use of cytokine- induced killer cells and cyclosporine for the treatment of aplastic anemia in a mouse model. J Interferon Cytokine Res. 2015, 5 (5):401-410

10 Zou Y, Bao J, Pan X, Lu Y, Liao S, Wang X, Wang G, Lin D. NKP30-B7-H6 interaction aggrava-

tes hepatocyte damage through up- regulation of interleukin-32 expression in hepatitis B virus-related acute-on-chronic liver failure. PLoS One. 2015, 10(8): e0134568.

11 Zhai FX, Liu XF, Fan RF, Long ZJ, Fang ZG, Lu Y, Zheng YJ, Lin DJ. RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukemia cell lines. J Cancer Res Clin Oncol. 2012, 138(3):439-449.


 

Contact

The Third Affiliated Hospital, Sun Yat-sen University

600 Tianhe Road